Project Grant H79TI085227
- This federal Project Grant award of $375,000 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will support Intercambios Puerto Rico, Inc. in addressing high rates of substance use disorder (SUD) and co-occurring disorder (COD) in Eastern Puerto Rico. The program will serve 150 individuals in the first year and 175 individuals per year in years 2 and...
- The Los Angeles LGBT Center (the Center) was awarded a $150,000 Project Grant under the HIV-Related Training and Technical Assistance program (CFDA 93.145) by the U.S. Department of Health and Human Services' HIV/AIDS Bureau. The grant will fund the establishment of a Transition in Care RN position to enhance early engagement and retention in care for low-income and underserved people living with HIV (PLWH) in Los Angeles. The initiative aims to improve linkage to care by ensuring newly...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research on the influence of social networks on HIV testing and pre-exposure prophylaxis (PrEP) care among young Latin American gay, bisexual, and other men who have sex with men (GBMSM). The $485,131 award to the New York Blood Center, Inc. is focused on understanding how social capital, social bonding, and network stress within the local and...
- The Lesbian & Gay Community Services Center, Inc. (The Center) in New York City was awarded a $375,000 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant, titled "Supporting LGBTQ Youth in NYC through Prevention, Resources, Information, Data, and Evaluation (PRIDE)," aims to reduce substance use and related...
- This federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will provide $2,605,000 to Bienestar Human Services, Inc., a non-profit organization based in Los Angeles, California. The award will fund an initiative to deliver same-day hepatitis C virus (HCV) testing and treatment, integrated behavioral health care, and peer-led...
- The U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) awarded a $2,000,000 Project Grant under the Grants for New and Expanded Services under the Health Center Program (CFDA 93.527) to Project Vida Health Center (PVHC), a Federally Qualified Health Center in El Paso, Texas. The grant will fund a two-year project from December 1, 2024 to November 30, 2026 to provide a continuum of medical, behavioral, and substance use disorder care, as well as peer...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $375,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Centro Deambulantes Cristo Pobre, a nonprofit organization located in Ponce, Puerto Rico. The three-year grant will fund an ambulatory-based recovery program focused on providing evidence-based treatment for adults experiencing substance use disorders (SUD) and...
- This Project Grant award of $3,907,500 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will fund the "HEP C FREE PUERTO RICO INTEGRATED CARE PILOT" delivered by Mennonite General Hospital, Inc. (MGHPR). The project aims to screen 10,000 high-risk adults, initiate direct-acting antiviral (DAA) therapy in 1,150, and confirm cure (SVR12)...
- This $549,216 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493) will expand the Hawaii Health & Harm Reduction Center's capacity to provide behavioral health services, including mental health and substance use disorder treatment, for the transgender community in Honolulu County. The grant will fund an integrated clinical team comprising an addiction medicine specialist, medical director,...
- This Project Grant award of $1,344,412 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to increase HIV and substance misuse prevention and treatment among adolescent and young adult (AYA) sexual violence survivors. The University of Texas Health Science Center at Houston (UTHealth) will tailor existing Sexual Assault Nurse Examiner (SANE) services to include same-day HIV prophylaxis and substance use prevention, using...
PROJECT ELIA PROPOSES TO INCREASE THE ENGAGEMENT IN CARE FOR LATINO MEN WHO HAVE SEX WITH MEN AND TRANSGENDER INDIVIDUALS WHO ARE UNDERREPRESENTED INDIVIDUAL WITH SUD OR COD. - THIS PROJECT IS ELIGIBLE FOR 5 ADDITIONAL POINTS AS THE ORGANIZATION IS IN HARRIS COUNTY TEXAS. FUNDACION LATINOAMERICANA DE ACCION SOCIAL INC. LATIN AMERICAN FOUNDATION FOR SOCIAL ACTION ALSO KNOWN AS FLAS PROPOSES PROJECT ELIA TO INCREASE THE ENGAGEMENT IN CARE FOR LATINO MEN WHO HAVE SEX WITH MEN AND TRANSGENDER INDIVIDUALS WHO ARE UNDERREPRESENTED INDIVIDUALS WITH SUBSTANCE USE DISORDERS AND OR CO-OCCURRING SUBSTANCE USE AND MENTAL DISORDERS WHO ARE AT RISK FOR HIV DISEASE OR PLWHA AND RECEIVE ART RESIDING WITHIN THE CITY OF HOUSTONS HEALTH DEPARTMENT BUREAU OF HIV-STD VIRAL HEPATITIS PREVENTION IDENTIFIES THE FOLLOWING HIGH PRIORITY ZIP CODES 77031, 77036, 77072, 77074, 77081, AND 77099 WHERE HIV TRANSMISSION CONTINUES TO OCCUR DISPROPORTIONATELY IN CERTAIN POPULATION GROUPS AND GEOGRAPHIC COMMUNITIES. FLAS PLANS TO TARGET SIX DESIGNATED HIGH PRIORITY ZIP CODES WHICH ALLOWS FLAS TO CONCENTRATE SERVICES AND RESOURCES ON THE ZIP CODES MOST IN NEED. TABLE 1 SPELLS OUT THE OVERALL GOAL AND OBJECTIVES OF THE PROPOSED PROJECT NAMED PROJECT ELIA. SERVICES ARE ALSO AVAILABLE TO THE SEX AND OR NEEDLE-SHARING PARTNERS OF THE POPULATION OF FOCUS. TOTAL GOALS FOR THE 5 YEARS OF THE PROGRAM: COMMUNITY AND VENUE BASED OUTREACH 3500 HARM REDUCTION SERVICES 2300 HIV TESTING SERVICES-HEPATITIS C TESTING SERVICES 2800 PREP OR ART PRESCRIBING 825 SERVICE LINKAGE AND CASE MANAGEMENT 500 PRIMARY CARE AND HIV-RELATED PRIMARY CARE 750 MENTAL HEALTH TREATMENT 475 SUDS AND COD TREATMENT 475 RECOVERY SUPPORT SERVICES 475 PROJECT ELIA GOAL: HLMSM AND TG WHO ARE UNDERREPRESENTED INDIVIDUALS WITH SUBSTANCE USE DISORDERS AND/OR CO-OCCURRING SUBSTANCE USE AND MENTAL DISORDERS WHO ARE AT RISK FOR HIV DISEASE OR PLWHA AND RECEIVE ART REMAIN ENGAGED IN CARE TO IMPROVE AND OR MAINTAIN POSITIVE HEALTH OUTCOMES. FLAS HAS AT LEAST TWO YEARS OF EXPERIENCE AS A TEXAS LICENSED SUDS OUTPATIENT ADULT TREATMENT PROVIDER. SERVICES DIRECTLY PROVIDED BY FLAS UNDER THIS RFA INCLUDE SCREENING AND ASSESSMENT INCLUDING SBIRT, INTENSIVE AND SUPPORTIVE OUTPATIENT PROGRAMS, MENTAL HEALTH COUNSELING, CLINICAL CASE MANAGEMENT, HIV-STI, HBV, HCV TESTING COUNSELING REFERRAL HARM REDUCTION SERVICES, PREP SERVICES AND RECOVERY SUPPORT SERVICES. TWO COLLABORATORS 1. EL CENTRO DE CORAZON COMMUNITY HEALTH CENTER 2. MONTROSE CENTER PROVIDED AN MOA AND LETTER OF COMMITMENT INCLUDING A STATEMENT ATTESTING TO THE TWO YEARS OF THE EXPERIENCE REQUIREMENT. THE LISTED EVIDENCED-BASED PRACTICES AND OR EVIDENCED-BASED INTERVENTIONS ARE EMBEDDED WITHIN PROJECT ELIA'S CARE CONTINUUM AS WELL AS ADAPTED AND OR TAILORED FOR HLMSM AND TG SEEKING SAFETY, MATRIX, IOP, COGNITIVE BEHAVIORAL THERAPY, RELAPSE PREVENTION THERAPY, IMPLICIT BIAS TRAINING, MOTIVATIONAL INTERVIEWING, AND THE INDIGENOUS LEADER OUTREACH MODEL.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $500.0k | 9/23/25 | ||
| Not listed | $500.0k | 6/27/24 | ||
| Not listed | $500.0k | 7/26/23 | ||
| Not listed | $500.0k | 7/26/23 | ||
| Not listed | $500.0k | 9/15/22 |